Publications

Search our bibliography using the filters on the right-hand side.

Displaying 401 through 450 of 644 publications.

Rothman KJ, Evans S. More on JAMA's policy on industry sponsored studies. BMJ. 2006 Feb 25;332(7539):489.

Ehrenstein V, Sorensen HT, Pedersen L, Larsen H, Holsteen V, Rothman KJ. Apgar score and hospitalization for epilepsy in childhood: a registry-based cohort study. BMC Public Health. 2006 Feb 1;6:23.

Missmer SA, Suarez L, Felkner M, Wang E, Merrill AH, Rothman KJ. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ Health Perspect. 2006 Feb 1;114(2):237-41.

Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J Infect Dis. 2006 Jan 1;193(6):898.

Langagergaard V, Gislum M, Skriver MV, Norgard B, Lash TL, Rothman KJ, Sorensen HT. Birth outcome in women with breast cancer. Br J Cancer. 2006 Jan 1;94(1):142-6.

Norgaard M, Larsson H, Pedersen G, Schonheyder HC, Rothman KJ, Sorensen HT. Short-term mortality of bacteraemia in elderly patients with haematological malignancies. Br J Haematol. 2006 Jan 1;132(1):25-31.

Sorensen HT, Pedersen L, Norgaard M, Wogelius P, Rothman KJ. Maternal asthma, preeclampsia and risk of hypospadias. Epidemiology. 2005 Nov 1;16(6):806-7.

Ellison RC, Rothman KJ, Zhang Y, Djousse L. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med. 2005 Oct 1;29(3):243.

Rothman KJ, Arellano F. Elevating the level of scientific discourse. Int J Occup Environ Health. 2005 Sep 1;11(3):327-8.

Arellano FA, Wentworth CE, May C, Verma A, Rivero E, Rothman KJ. Use of prescription Cyclo-Oxygenase 2 Inhibitors (COX-2) and non COX-2 Non-Steroidal Anti-Inflammatory Drugs (NSAID) in a UK population. Poster presented at the 21st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; June 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Sep; 14(Suppl S2):S141. doi: 10.1002/pds.1136

Arellano FA, Wentworth CE, May C, Verma A, Rivero E, Rothman KJ. Use of prescription cyclo-oxigenase 2 inhibitors (COX-2) and non cox-2 non-steroidal anti-inflammatory drugs (NSAIDS) in a UK population. Pharmacoepidemiol Drug Saf. 2005 Jul;14(Suppl 1):S141.

Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005 May 1;161(9):891-8.

Cvetkovski RS, Rothman KJ, Olsen J, Mathiesen B, Iversen L, Johansen JD, Agner T. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol. 2005 Jan 1;152(1):93-8.

Rothman KJ, Evans S. Extra scrutiny for industry funded trials. BMJ. 2005 Jan 1;331(7529):1350-1.

Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005 Jan 1;95(Suppl 1):S144-150.

Nielsen GL, Norgard B, Puho E, Rothman KJ, Sorensen HT, Czeizel AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med. 2005 Jan 1;22(6):693-6.

Fischer T, Johnsen SP, Pedersen L, Gaist D, Sorensen HT, Rothman KJ. Seasonal variation in hospitalization and case fatality of subarachnoid hemorrhage - A nationwide Danish study on 9,367 patients. Neuroepidemiology. 2005 Jan 1;24(1-2):32-7.

Skriver MV, Pedersen L, Stang P, Lund L, Rothman KJ, Sorensen HT. The month of birth does not affect the risk of hypospadias. Eur J Epidemiol. 2004 Dec 1;19(12):1135-6.

Rothman KJ, Lanes S, Sacks ST. Measuring drug effects means getting a clearer signal. Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):527-8.

Rothman KJ. Interaction and evolution in epidemiology. Soz Praventivmed. 2004 Apr 1;49(2):105-6.

Rothman KJ, Mahon BE. Confounding and effect-measure modification in the evaluation of immunogenic agents. Eur J Epidemiol. 2004 Mar;19(3):205-7.

Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004 Jan 1;13(8):519-23.

Rothman KJ. My interview with John Snow. Epidemiology. 2004 Jan 1;15(5):640-4.

Rothman KJ. A potential bias in safety evaluation during open-label extensions of randomized clinical trials. Pharmacoepidemiol Drug Saf. 2004 Jan 1;13(5):295-8.

Enger C, Nordstrom BL, Thakrar B, Sacks S, Rothman KJ. Health outcomes among patients receiving oseltamivir. Pharmacoepidemiol Drug Saf. 2004 Jan 1;13(4):227-37.

Sturmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Comparing analytic strategies using propensity and disease risk scores: the example of nonsteroidal antiinflammatory drugs (NSAID) and short-term mortality in the elderly. Am J Epidemiol. 2004 Jan 1;159(11):S67.

Arana A, Castellsague J, Trave F, Perez-Gutthann S, Rothman KJ, Arellano FM. Early estimation of excess risk of serious cutaneous reactions for newly marketed drugs. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):165.

Langagergaard V, Norgard B, Mellemkjaer L, Pendersen L, Rothman KJ, Sorensen HT. Seasonal variation in month of birth and diagnosis in children and adolescents with Hodgkin's disease and non-Hodgkin's lymphoma. J Pediatr Hematol Oncol. 2003 Jul;25(7):534-8.

Rothman KJ, Funch DP, Alfredson T, Brady J, Dreyer NA. Randomized field trial of vaginal douching, pelvic inflammatory disease, and pregnancy. Epidemiology. 2003 May;14(3):340-8.

Michels KB, Rothman KJ. Update on unethical use of placebos in randomised trials. Bioethics. 2003 Apr;17(2):188-204.

Moore LL, Bradlee ML, Singer MR, Rothman KJ, Milunsky A. Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology. 2003 Mar;14(2):200-5.

Djoussé L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Effect of serum albumin and bilirubin on the risk of myocardial infarction (The Framingham Offspring Study). Am J Cardiol. 2003 Feb 15;91(4):485-8.

Djousse L, Rothman KJ, Cupples LA, Arnett DK, Ellison RC. Relation between serum albumin and carotid atherosclerosis the NHLBI family heart study. Stroke. 2003 Jan 1;34(1):53-7.

Rothman KJ, Wentworth CE. Mortality of cystic fibrosis patients treated with tobramycin solution for inhalation. Epidemiology. 2003 Jan;14(1):55-9.

Moore LL, Bradlee ML, Singer MR, Rothman KJ, Milunsky A. Chromosomal anomalies among the offspring of women with gestational diabetes. Am J Epidemiol. 2002 Apr 15;155(8):719-24.

Frost L, Johnsen SP, Pedersen L, Husted S, Engholm G, Sorensen HT, Rothman KJ. Seasonal variation in hospital discharge diagnosis of atrial fibrillation: a population-based study. Epidemiology. 2002 Mar;13(2):211-5.

Loughlin JE, Cole JA, Rothman KJ, Johnson ES. Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients. Ann Allergy Asthma Immunol. 2002 Jan 1;88(3):319-25.

Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation. 2002 Jan 1;106(23):2919-24.

Rothman KJ, Ray W. Should cases with a 'known' cause of their disease be excluded from study? (Commentary). Pharmacoepidemiol Drug Saf. 2002 Jan 1;11(1):11-4.

Rothman KJ, Michels KB. When is it appropriate to use a placebo arm in a trial? In: Guess HA, Kleinman A, Kusek JW, Engel LW, editors. The science of the placebo: toward an interdisciplinary research agenda. London: United Kingdom. BMJ Books; 2002.

Rothman KJ, Ray W. Should epidemiologists exclude cases with a known cause of their disease? Pharmacoepidemiol Drug Saf. 2002;11:11-4.

Czeizel AE, Rothman KJ. Does relaxed reproductive selection explain the decline in male reproductive health? A new hypothesis. Letter to Edtior. Epidemiology. 2002 Jan;13(1):113-4.

Rothman KJ. My actual beliefs. J Clin Epidemiol. 2001 Dec 1;54(12):1275. doi: 10.1016/S0895-4356(01)00419-X

Rothman KJ. Ultrasound and handedness. Epidemiology. 2001 Nov 1;12(6):601.

Ellison RC, Zhang Y, McLennan CE, Rothman KJ. Exploring the relation of alcohol consumption to risk of breast cancer. Am J Epidemiol. 2001 Oct 15;154(8):740-7.

Rothman KJ. Cellular telephones and risk of brain tumours. Lancet. 2001 Mar 24;357(9260):961.

Sorensen HT, Pedersen L, Olsen JH, Rothman KJ. Seasonal variation in month of birth and diagnosis of early childhood acute lymphoblastic leukemia. JAMA. 2001 Jan 10;285(2):168-9.

Rothman KJ. Sizing up research. Lancet. 2001 Jan 1;357(9259):890.

Rothman KJ. Cellular telephones and risk of brain tumours - Reply. Lancet. 2001 Jan 1;357(9260):961.

Rothman KJ, Cann CI, Lang JM. Transition for epidemiology. Epidemiology. 2001 Jan 1;12(2):147.